Velocity Energy Inc. announced the purchase of producing natural gas wells and partially developed acreage in the Appalachian region in the Northeastern United States. Velocity Energy Inc. purchased the assets from a private company and did not disclose the purchase … Continue reading →

New Generation Biofuels, Inc. holds an exclusive license for North America, Central America and the Caribbean to commercialize proprietary technology to manufacture alternative biofuels from plant oils and animal fats. The company then markets these products as a new class … Continue reading →

Leading Chinese national liquid and fertilizer manufacturer, China Agritech, Inc., announced today that it is increasing its annual net revenue and net income guidance for the year ending December 31, 2009. This increase follows a 56.9% increase in net revenues … Continue reading →

Helen of Troy Ltd. designs, develops and markets brand-name personal care and household consumer products. The company yesterday announced its financial results for the second quarter and half-year ended August 31, 2009, posting increases in net earnings and record sales. … Continue reading →

AVANIR Pharmaceuticals, Inc., a biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders, recently announced that the company has received a “Notice of Allowance” from the United States Patent and … Continue reading →

SurModics, Inc. announced yesterday that it has signed an exclusive agreement with the Roche Group and Genentech for the licensing of its proprietary drug delivery system. This agreement will also establish a development process whereby a new, sustained-delivery formulation for … Continue reading →

First Advantage Corporation made an equity investment in EnticeLabs, Inc., a company that provides HR recruitment advertising services for both active and passive job seekers. The company did not disclose the amount of the investment. The investment in Enticelabs, Inc. … Continue reading →

It is often said that the quiet ones are the ones to watch. They go about their business with little noise or capital expense, then all of a sudden “pop” with profit. It is always difficult to spot these companies … Continue reading →

AVI BioPharma, Inc., developer of RNA-based drugs, announced today that it has received expanded contract funding from the government for the development of the Investigational New Drug (IND) data package for its candidate drug AVI-7012, which is designed to treat … Continue reading →

Inovio Biomedical is engaged in the design, development and delivery of DNA vaccines for the prevention and treatment of cancers and infectious diseases. The company today announced that a combination of its synthetic consensus (SynCon) H1N1 influenza vaccine candidates achieved … Continue reading →